Medical Communications

It’s only four months since Gilead completed its buy-out of Kite Pharma for $11.9 billion, but it’s already moving quickly …

Since Sanofi released further data from a six-year study which showed that the risk of a severe dengue reaction is …

Sage Therapeutics’ stock rocketed after it announced that Phase 2 results for its treatment for major depressive disorder (MDD) were …

Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …

Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from …

Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …

New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …

We are proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma procurement …

Mundipharma has announced that it has appointed Philippe Mazas as its new Chief Information Officer (CIO). Mazas boasts nearly 20 …

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …

It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …

We’re officially into December and only one month away from the end of the year. Among our top news this …

Scott Gottlieb, FDA commissioner, was speaking in front of the House Committee on Energy and Commerce, regarding the 21st Century …

Image Credit:  Marco VerchAs the US languishes in the midst of an opioid crisis which President Trump declared national emergency …